Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 117.26B | 115.11B | 113.51B | 107.85B | 98.15B | 218.35B |
Gross Profit | 59.20B | 53.30B | 55.63B | 53.44B | 48.29B | 49.45B |
EBITDA | 9.71B | 10.17B | 9.63B | 7.97B | 5.26B | 3.02B |
Net Income | 2.09B | 3.48B | 2.78B | 1.89B | -775.00M | -4.95B |
Balance Sheet | ||||||
Total Assets | 118.09B | 114.39B | 115.36B | 118.34B | 119.38B | 123.42B |
Cash, Cash Equivalents and Short-Term Investments | 4.44B | 2.59B | 3.73B | 3.24B | 4.10B | 5.62B |
Total Debt | 6.30B | 4.62B | 6.04B | 12.58B | 16.84B | 17.22B |
Total Liabilities | 80.11B | 75.81B | 78.05B | 83.76B | 86.07B | 89.78B |
Stockholders Equity | 37.98B | 38.58B | 37.32B | 34.59B | 33.31B | 33.64B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 2.79B | 6.59B | 4.67B | -1.12B | 146.00M |
Operating Cash Flow | 0.00 | 6.73B | 10.17B | 7.56B | 2.50B | 4.30B |
Investing Cash Flow | 0.00 | -3.90B | -2.19B | -3.02B | -3.30B | -3.61B |
Financing Cash Flow | 0.00 | -3.97B | -7.49B | -5.40B | -715.00M | 1.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $616.69B | 19.48 | 7.58% | 2.42% | 6.52% | -31.67% | |
72 Outperform | ¥90.47B | 222.82 | ― | 0.88% | 1.38% | -87.76% | |
71 Outperform | $498.38B | 12.01 | 8.54% | 1.83% | 0.42% | 20.25% | |
65 Neutral | ¥78.49B | 13.59 | ― | 1.03% | 7.55% | 89.45% | |
63 Neutral | €256.04B | 20.66 | 4.63% | 2.07% | 2.86% | -74.87% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥923.83B | 16.07 | 10.01% | 2.45% | 0.47% | -4.34% |